Search company, investor...

Predict your next investment

Venture Capital
atlasventure.com

Investments

805

Funds

24

Partners & Customers

4

About Atlas Venture

Atlas Venture is an early stage venture capital firm investing in biotech innovation.

Headquarters Location

25 First Street Suite 303

Cambridge, Massachusetts, 02141,

United States

617-588-2600

Want to inform investors similar to Atlas Venture about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Expert Collections containing Atlas Venture

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Atlas Venture in 2 Expert Collections, including Synthetic Biology.

S

Synthetic Biology

382 items

C

CB Insights Healthcare Smart Money Investors - 2020

25 items

Track the world's top-performing VC investors in healthcare. Firms are presented in alphabetical order.

Latest Atlas Venture News

Chroma Medicine Raises $135M in Series B Financing

Mar 1, 2023

Chroma Medicine , a Cambridge, MA-based genomic medicine company, raised $135M in Series B funding. The round was led by GV, with participation from additional new investors ARCH Venture Partners, DCVC Bio, Mubadala Capital, Sixth Street, and all existing investors Alexandria Venture Investments, Atlas Venture, Casdin Capital, Cormorant Asset Management, Janus Henderson Investors, Newpath Partners, Omega Funds, Osage University Partners, Sofinnova Partners, T Rowe Price, and Wellington Management. The company intends to use the funds to progress its single-dose epigenetic editing therapies and support expansion of novel genetic medicine platform designed to enable precise gene regulation while preserving genomic integrity. Led by CEO Catherine Stehman-Breen, Chroma Medicine is a biotechnology company providing genomic medicines that harness the cells’ innate mechanism for gene regulation to precisely and durably silence, activate, and multiplex genes using a single platform, without changing the underlying DNA sequence. This approach enables the company to more effectively address a wide range of diseases and to target multiple pathways for complex diseases. FinSMEs 01/03/2023

Dec 30, 2022
Disc Medicine

Atlas Venture Investments

805 Investments

Atlas Venture has made 805 investments. Their latest investment was in Chroma Medicine as part of their Series B on March 3, 2023.

CBI Logo

Atlas Venture Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

3/1/2023

Series B

Chroma Medicine

$135M

No

7

12/30/2022

PIPE

Disc Medicine

$53.5M

No

1

12/23/2022

Seed VC - II

Amagma Therapeutics

$10M

Yes

1

12/22/2022

Series C - II

Subscribe to see more

$99M

Subscribe to see more

10

10/14/2022

Series A

Subscribe to see more

$99M

Subscribe to see more

10

Date

3/1/2023

12/30/2022

12/23/2022

12/22/2022

10/14/2022

Round

Series B

PIPE

Seed VC - II

Series C - II

Series A

Company

Chroma Medicine

Disc Medicine

Amagma Therapeutics

Subscribe to see more

Subscribe to see more

Amount

$135M

$53.5M

$10M

$99M

$99M

New?

No

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

7

1

1

10

10

Atlas Venture Acquisitions

2 Acquisitions

Atlas Venture acquired 2 companies. Their latest acquisition was NovusPharma on September 20, 1999.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

9/20/1999

Convertible Note

$99M

Management Buyout

1

5/27/1993

Subscribe to see more

$99M

Subscribe to see more

10

Date

9/20/1999

5/27/1993

Investment Stage

Convertible Note

Companies

Subscribe to see more

Valuation

$99M

$99M

Total Funding

Note

Management Buyout

Subscribe to see more

Sources

1

10

Atlas Venture Fund History

24 Fund Histories

Atlas Venture has 24 funds, including Atlas Venture Fund XIII.

Closing Date

Fund

Fund Type

Status

Amount

Sources

3/3/2022

Atlas Venture Fund XIII

$450M

1

7/6/2020

Accomplice Fortuity Pool

$110M

1

6/5/2020

Atlas Venture Fund XII

$400M

2

5/6/2020

Pride Fund

$99M

10

1/2/2019

Atlas Venture Opportunity Fund I

Subscribe to see more

Subscribe to see more

$99M

10

Closing Date

3/3/2022

7/6/2020

6/5/2020

5/6/2020

1/2/2019

Fund

Atlas Venture Fund XIII

Accomplice Fortuity Pool

Atlas Venture Fund XII

Pride Fund

Atlas Venture Opportunity Fund I

Fund Type

Subscribe to see more

Status

Subscribe to see more

Amount

$450M

$110M

$400M

$99M

$99M

Sources

1

1

2

10

10

Atlas Venture Partners & Customers

4 Partners and customers

Atlas Venture has 4 strategic partners and customers. Atlas Venture recently partnered with AbCellera on August 8, 2022.

Date

Type

Business Partner

Country

News Snippet

Sources

8/3/2022

Licensor

Canada

AbCellera and Atlas Venture to collaborate on new company for therapeutic antibody discovery

AbCellera Biologics Inc. and Atlas Venture have announced a multi-target partnership to discover therapeutic antibodies for up to three drug targets that can be developed and commercialized by a stealth-stage Atlas-backed company .

6

11/18/2014

Partner

United States

Subscribe to see more

Subscribe to see more

10

3/17/2014

Partner

United States

Subscribe to see more

Subscribe to see more

10

12/15/2011

Partner

Ireland

Subscribe to see more

Subscribe to see more

10

Date

8/3/2022

11/18/2014

3/17/2014

12/15/2011

Type

Licensor

Partner

Partner

Partner

Business Partner

Country

Canada

United States

United States

Ireland

News Snippet

AbCellera and Atlas Venture to collaborate on new company for therapeutic antibody discovery

AbCellera Biologics Inc. and Atlas Venture have announced a multi-target partnership to discover therapeutic antibodies for up to three drug targets that can be developed and commercialized by a stealth-stage Atlas-backed company .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

6

10

10

10

Atlas Venture Team

24 Team Members

Atlas Venture has 24 team members, including , .

Name

Work History

Title

Status

Michiel de Haan

Founder

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Michiel de Haan

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Work History

Title

Founder

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.